Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial

Alexander V. Louie; Erik van Werkhoven; Hanbo Chen; Egbert F. Smit; Marinus A. Paul; Joachim Widder; Harry J. M. Groen; Ben E. E. M. van den Borne; Katrien De Jaeger; Ben J. Slotman; Suresh Senan

doi:10.1016/j.radonc.2015.08.011

Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial

Alexander V. Louie^*, Erik van Werkhoven, Hanbo Chen, Egbert F. Smit, Marinus A. Paul, Joachim Widder, Harry J. M. Groen, Ben E. E. M. van den Borne, Katrien De Jaeger, Ben J. Slotman, Suresh Senan

^*Bijbehorende auteur voor dit werk

Guided Treatment in Optimal Selected Cancer Patients (GUTS)

Onderzoeksoutput: Article › Academic › peer review

72 Citaten (Scopus)

Samenvatting

We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Originele taal-2	English
Pagina's (van-tot)	44-48
Aantal pagina's	5
Tijdschrift	Radiotherapy and Oncology
Volume	117
Nummer van het tijdschrift	1
DOI's	https://doi.org/10.1016/j.radonc.2015.08.011
Status	Published - okt.-2015

Toegang tot document

10.1016/j.radonc.2015.08.011

Handle.net

Permanente koppeling

Document onder embargo

Patient reported outcomes following stereotactic ablative radiotherapy or surgery
Final publisher's version, 323 KB
Kopie aanvragen

Citeer dit

Louie, A. V., van Werkhoven, E., Chen, H., Smit, E. F., Paul, M. A., Widder, J., Groen, H. J. M., van den Borne, B. E. E. M., De Jaeger, K., Slotman, B. J., & Senan, S. (2015). Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial. Radiotherapy and Oncology, 117(1), 44-48. https://doi.org/10.1016/j.radonc.2015.08.011

@article{0af7d6ed250448bab4fc6125732a59dd,

title = "Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial",

abstract = "We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.",

keywords = "Lung cancer, Quality of life, Patient reported outcomes, SABR, SBRT, Surgery, QUALITY-OF-LIFE, BODY RADIOTHERAPY, CLINICAL-TRIALS, INSTRUMENT, SURVIVAL, THERAPY, QLQ-C30",

author = "Louie, {Alexander V.} and {van Werkhoven}, Erik and Hanbo Chen and Smit, {Egbert F.} and Paul, {Marinus A.} and Joachim Widder and Groen, {Harry J. M.} and {van den Borne}, {Ben E. E. M.} and {De Jaeger}, Katrien and Slotman, {Ben J.} and Suresh Senan",

year = "2015",

month = oct,

doi = "10.1016/j.radonc.2015.08.011",

language = "English",

volume = "117",

pages = "44--48",

journal = "Radiotherapy and Oncology",

issn = "0167-8140",

publisher = "ELSEVIER IRELAND LTD",

number = "1",

}

Louie, AV, van Werkhoven, E, Chen, H, Smit, EF, Paul, MA, Widder, J, Groen, HJM, van den Borne, BEEM, De Jaeger, K, Slotman, BJ & Senan, S 2015, 'Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer: Results from the ROSEL multicenter randomized trial', Radiotherapy and Oncology, vol. 117, nr. 1, blz. 44-48. https://doi.org/10.1016/j.radonc.2015.08.011

TY - JOUR

T1 - Patient reported outcomes following stereotactic ablative radiotherapy or surgery for stage IA non-small-cell lung cancer

T2 - Results from the ROSEL multicenter randomized trial

AU - Louie, Alexander V.

AU - van Werkhoven, Erik

AU - Chen, Hanbo

AU - Smit, Egbert F.

AU - Paul, Marinus A.

AU - Widder, Joachim

AU - Groen, Harry J. M.

AU - van den Borne, Ben E. E. M.

AU - De Jaeger, Katrien

AU - Slotman, Ben J.

AU - Senan, Suresh

PY - 2015/10

Y1 - 2015/10

N2 - We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

AB - We report quality of life and indirect costs from patient reported outcomes from the ROSEL randomized control trial comparing stereotactic ablative radiotherapy (SABR, also known as stereotactic body radiotherapy or SBRT) versus surgical resection for medically operable stage IA non-small cell lung cancer. ROSEL closed prematurely after accruing and randomizing 22 patients. This exploratory analysis found the global health related quality of life and indirect costs to be significantly favorable and cheaper, with SABR. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

KW - Lung cancer

KW - Quality of life

KW - Patient reported outcomes

KW - SABR

KW - SBRT

KW - Surgery

KW - QUALITY-OF-LIFE

KW - BODY RADIOTHERAPY

KW - CLINICAL-TRIALS

KW - INSTRUMENT

KW - SURVIVAL

KW - THERAPY

KW - QLQ-C30

U2 - 10.1016/j.radonc.2015.08.011

DO - 10.1016/j.radonc.2015.08.011

M3 - Article

SN - 0167-8140

VL - 117

SP - 44

EP - 48

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

IS - 1

ER -